SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-15-007229
Filing Date
2015-02-10
Accepted
2015-02-10 06:00:43
Documents
1
Group Members
L&L TECHNOLOGIES, LLCLEDER LABORATORIES, INC.LEDERMAN & CO., LLCSTARLING PHARMACEUTICALS, INC.TARGENT PHARMACEUTICALS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v401009_sc13da.htm SC 13D/A 165655
  Complete submission text file 0001144204-15-007229.txt   167256
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86436 | Film No.: 15590299
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Filed by) CIK: 0001563420 (see all company filings)

Type: SC 13D/A